Skip to main content

Advertisement

SpringerLink
Log in

Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus

  • Review
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Pemphigus is a general term for a rare group of autoimmune diseases which result in the formation of blisters on the skin and oral cavity. Although there is no way to prevent autoimmune diseases, some factors may trigger pemphigus initiation in susceptible individuals or be exacerbated in affected patients. Recognition of these triggers, based on the latest studies and experiences is essential and should be updated every few years. In this study, several triggers, including different drugs and treatments, diseases, vaccines, genetic factors, nutrients, micronutrients, pregnancy, stress, and various other triggers have been discussed. Some possible triggers, such as blood antigens and the effect of seasons have also been discussed briefly. Moreover, some protective factors against pemphigus have been reviewed. Considering the molecular mechanism of pemphigus and immune response alteration during this disease, some possible triggers have been suggested and discussed. Although those triggers may be a real threat, more studies are needed to support these hypotheses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Abasq C, Mouquet H, Gilbert D, Tron F, Grassi V, Musette P, Joly P (2009) ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus. Arch Dermatol 145:529–535

    Article  CAS  PubMed  Google Scholar 

  2. Abida O, Zitouni M, Kallel-Sellami M, Mahfoudh N, Kammoun A, Ben Ayed M, Masmoudi A, Mokni M, Fezzaa B, Ben Osman A, Kammoun MR, Turki H, Makni H, Gilbert D, Joly P, Tron F, Makni S, Masmoudi H, The Franco-Tunisian Group for S, Research on P (2009) Tunisian endemic pemphigus foliaceus is associated with the HLA-DR3 gene: anti-desmoglein 1 antibody-positive healthy subjects bear protective alleles. Br J Dermatol 161:522–527

    Article  CAS  PubMed  Google Scholar 

  3. Agmon-Levin N, Theodor E, Segal RM, Shoenfeld Y (2013) Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol 45:256–266

    Article  CAS  PubMed  Google Scholar 

  4. Ambay A, Stratman E (2006) Ionizing radiation-induced pemphigus foliaceus. J Am Acad Dermatol 54:251–252

    Article  PubMed  Google Scholar 

  5. Amber KT, Staropoli P, Shiman MI, Elgart GW, Hertl M (2013) Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris. Exp Dermatol 22:699–704

    Article  CAS  PubMed  Google Scholar 

  6. Aoki-Ota M, Kinoshita M, Ota T, Tsunoda K, Iwasaki T, Tanaka S, Koyasu S, Nishikawa T, Amagai M (2006) Tolerance induction by the blockade of CD40/CD154 interaction in pemphigus vulgaris mouse model. J Investig Dermatol 126:105–113

    Article  CAS  PubMed  Google Scholar 

  7. Asothai R, Anand V, Das D, Antil PS, Khandpur S, Sharma VK, Sharma A (2015) Distinctive Treg associated CCR4-CCL22 expression profile with altered frequency of Th17/Treg cell in the immunopathogenesis of pemphigus vulgaris. Immunobiology 220:1129–1135

    Article  CAS  PubMed  Google Scholar 

  8. Badri T, Hammami H, Lachkham A, Benmously-Mlika R, Mokhtar I, Fenniche S (2011) Radiotherapy-induced pemphigus vulgaris with autoantibodies targeting a 110 kDa epidermal antigen. Int J Dermatol 50:1475–1479

    Article  CAS  PubMed  Google Scholar 

  9. Basir N, Telisinghe PU, Chong VH (2015) Gastric cancer and paraneoplastic pemphigus. Indian J Surg 77:545–546

    Article  PubMed  PubMed Central  Google Scholar 

  10. Baum S, Scope A, Barzilai A, Azizi E, Trau H (2006) The role of IVIg treatment in severe pemphigus vulgaris. J Eur Acad Dermatol Venereol 20:548–552

    Article  CAS  PubMed  Google Scholar 

  11. Bauza A, Del Pozo LJ, Saus C, Martin A (2009) Pemphigus-like lesions induced by imiquimod. Clin Exp Dermatol 34:e60–e62. https://doi.org/10.1111/j.1365-2230.2008.03181.x

    Article  CAS  PubMed  Google Scholar 

  12. Berkun Y, Mimouni D, Shoenfeld Y (2005) Pemphigus following hepatitis B vaccination—coincidence or causality? Autoimmunity 38:117–119

    Article  PubMed  Google Scholar 

  13. Beutner EH, Jordon RE (1964) Demonstration of skin antibodies in sera of pemphigus vulgaris patients by indirect immunofluorescent staining. Proc Soc Exp Biol Med 117:505–510

    Article  CAS  PubMed  Google Scholar 

  14. Brenner S, Bar-Nathan EA (1984) Pemphigus vulgaris triggered by emotional stress. J Am Acad Dermatol 11:524–525

    Article  Google Scholar 

  15. Brenner S, Bialy-Golan A, Crost N (1997) Dipyrone in the induction of pemphigus. J Am Acad Dermatol 36:488–490

    Article  CAS  PubMed  Google Scholar 

  16. Brenner S, Tur E, Shapiro J, Ruocco V, D’Avino M, Ruocco E, Tsankov N, Vassileva S, Drenovska K, Brezoev P, Barnadas MA, Gonzalez MJ, Anhalt G, Nousari H, Ramos-e-Silva M, Pinto KT, Miranda MF (2001) Pemphigus vulgaris: environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire. Int J Dermatol 40:562–569

    Article  CAS  PubMed  Google Scholar 

  17. Brenner S, Wohl Y (2006) A burning issue: burns and other triggers in pemphigus. Cutis 77:145–146

    PubMed  Google Scholar 

  18. Brenner S, Wolf R, Ruocco V (1994) Contact pemphigus: a subgroup of induced pemphigus. Int J Dermatol 33:843–845

    Article  CAS  PubMed  Google Scholar 

  19. Brochado MJ, Nascimento DF, Campos W, Deghaide NH, Donadi EA, Roselino AM (2016) Differential HLA class I and class II associations in pemphigus foliaceus and pemphigus vulgaris patients from a prevalent Southeastern Brazilian region. J Autoimmun 72:19–24

    Article  CAS  PubMed  Google Scholar 

  20. Butt A, Burge SM (1995) Pemphigus vulgaris induced by captopril. Br J Dermatol 132:315–316

    Article  CAS  PubMed  Google Scholar 

  21. Buzon E, Perez-Bernal AM, de la Pena F, Rios JJ, Camacho F (1998) Pemphigus foliaceus associated with cilazapril. Acta Derm Venereol 78:227

    Article  CAS  PubMed  Google Scholar 

  22. Cai Y, Zhou J, Webb DC (2012) Estrogen stimulates Th2 cytokine production and regulates the compartmentalisation of eosinophils during allergen challenge in a mouse model of asthma. Int Arch Allergy Immunol 158:252–260

    Article  CAS  PubMed  Google Scholar 

  23. Calebotta A, Cirocco A, Giansante E, Reyes O (2004) Systemic lupus erythematosus and pemphigus vulgaris: association or coincidence. Lupus 13:951–953

    Article  CAS  PubMed  Google Scholar 

  24. Carcassi C, Cottoni F, Floris L, Vacca A, Mulargia M, Arras M, Boero R, La Nasa G, Ledda A, Pizzati A, Cerimele D, Contu L (1996) HLA haplotypes and class II molecular alleles in Sardinian and Italian patients with pemphigus vulgaris. Tissue Antigens 48:662–667

    Article  CAS  PubMed  Google Scholar 

  25. Carson PJ, Hameed A, Ahmed AR (1996) Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol 34:645–652

    Article  CAS  PubMed  Google Scholar 

  26. Cassano N, Mastrandrea V, Tampoia M, Filotico R, Vestita M, Vena GA (2009) Pemphigus vulgaris with circulating anti-desmoglein 3 and anti-BP180 antibodies: a case report and brief review of cases with coexistence of pemphigus vulgaris and bullous pemphigoid. J Biol Regul Homeost Agents 23:197–201

    CAS  PubMed  Google Scholar 

  27. Cetkovska P, Komorousova M, Lomicova I (2014) Management of a pemphigus with IgA and IgG antibodies and coexistent lung cancer. Dermatol Ther 27:236–239

    Article  PubMed  Google Scholar 

  28. Chow SC, Yeung EC, Ng CS, Wong RH, Fai To K, Wan IY (2015) Mediastinal follicular dendritic cell sarcoma with paraneoplastic pemphigus. Asian Cardiovasc Thorac Ann 23:732–734

    Article  PubMed  Google Scholar 

  29. Corsini E, Liesivuori J, Vergieva T, Van Loveren H, Colosio C (2008) Effects of pesticide exposure on the human immune system. Hum Exp Toxicol 27:671–680

    Article  CAS  PubMed  Google Scholar 

  30. Daneshpazhooh M, Chams-Davatchi C, Valikhani M, Aghabagheri A, Mortazavizadeh SM, Barzegari M, Akhyani M, Hallaji Z, Esmaili N, Ghodsi SZ (2011) Pemphigus and pregnancy: a 23-year experience. Indian J Dermatol Venereol Leprol 77:534

    Article  PubMed  Google Scholar 

  31. Daneshpazhooh M, Fatehnejad M, Rahbar Z, Balighi K, Ghandi N, Ghiasi M, Abedini R, Lajevardi V, Chams-Davatchi C (2016) Trauma-induced pemphigus: a case series of 36 patients. J Dtsch Dermatol Ges 14:166–171

    PubMed  Google Scholar 

  32. Dar SA, Akhter N, Haque S, Singh T, Mandal RK, Ramachandran VG, Bhattacharya SN, Banerjee BD, Das S (2016) Tumor necrosis factor (TNF)-alpha −308G/A (rs1800629) polymorphism distribution in North India and its association with pemphigus: case–control study and meta-analysis. Autoimmunity 49:179–187

    Article  CAS  PubMed  Google Scholar 

  33. De Simone C, Caldarola G, D’Agostino M, Zampetti A, Amerio P, Feliciani C (2008) Exacerbation of pemphigus after influenza vaccination. Clin Exp Dermatol 33:718–720

    Article  PubMed  Google Scholar 

  34. Di Zenzo G, Borradori L, Muller EJ (2017) The pathogenesis of pemphigus: controversy vs complexity. Exp Dermatol. https://doi.org/10.1111/exd.13176

    PubMed  Google Scholar 

  35. Downie JB, Dicostanzo DP, Cohen SR (1998) Pemphigus vegetans-Neumann variant associated with intranasal heroin abuse. J Am Acad Dermatol 39:872–875

    Article  CAS  PubMed  Google Scholar 

  36. Eberhard Y, Burgos E, Gagliardi J, Vullo CM, Borosky A, Pesoa S, Serra HM (2005) Cytokine polymorphisms in patients with pemphigus. Arch Dermatol Res 296:309–313

    Article  CAS  PubMed  Google Scholar 

  37. El-Far M, Halwani R, Said E, Trautmann L, Doroudchi M, Janbazian L, Fonseca S, van Grevenynghe J, Yassine-Diab B, Sekaly RP, Haddad EK (2008) T-cell exhaustion in HIV infection. Curr HIV/AIDS Rep 5:13–19

    Article  PubMed  Google Scholar 

  38. El-Komy MH, Samir N, Shaker OG (2014) Estimation of vitamin D levels in patients with pemphigus vulgaris. J Eur Acad Dermatol Venereol 28:859–863

    Article  CAS  PubMed  Google Scholar 

  39. Feldman RJ (2015) Paradoxical worsening of pemphigus vulgaris following rituximab therapy. Br J Dermatol 173:858–859

    Article  CAS  PubMed  Google Scholar 

  40. Fellner MJ, Wininger J (1978) Pemphigus erythematosus and heroin addiction. Int J Dermatol 17:308–311

    Article  CAS  PubMed  Google Scholar 

  41. Fryer EJ, Lebwohl M (1994) Pemphigus vulgaris after initiation of psoralen and UVA therapy for psoriasis. J Am Acad Dermatol 30:651–653

    Article  CAS  PubMed  Google Scholar 

  42. Fujita H, Iguchi M, Watanabe R, Asahina A (2007) Pemphigus foliaceus induced by bucillamine. Eur J Dermatol 17:98–99

    PubMed  Google Scholar 

  43. Gaido K, Dohme L, Wang F, Chen I, Blankvoort B, Ramamoorthy K, Safe S (1998) Comparative estrogenic activity of wine extracts and organochlorine pesticide residues in food. Environ Health Perspect 106(Suppl 6):1347–1351

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Ghaffarpour G, Jalali MH, Yaghmaii B, Mazloomi S, Soltani-Arabshahi R (2006) Chloroquine/hydroxychloroquine-induced pemphigus. Int J Dermatol 45:1261–1263

    Article  PubMed  Google Scholar 

  45. Gholizadeh N, Taghavi Zenouz A, Eslami H (2012) Pemphigus vulgaris associated with rheumatoid arthritis in a patient not taking penicillamine. J Dent Res Dent Clin Dent Prospects 6(1):33–35

    PubMed  PubMed Central  Google Scholar 

  46. Giordano CN, Sinha AA (2012) Cytokine networks in pemphigus vulgaris: an integrated viewpoint. Autoimmunity 45:427–439

    Article  CAS  PubMed  Google Scholar 

  47. Golberg O, Harman KE (2015) Drug-induced pemphigus. In: Katsambas AD, Lotti TM, Dessinioti C, D’Erme AM (eds) European handbook of dermatological treatments. Springer Berlin Heidelberg, Berlin, pp 725–730. https://doi.org/10.1007/978-3-662-45139-7_72

    Google Scholar 

  48. Goldberg I, Ingher A, Brenner S (2004) Pemphigus vulgaris triggered by rifampin and emotional stress. Skinmed 3:294

    Article  PubMed  Google Scholar 

  49. Goldberg I, Sasson A, Gat A, Srebrnik A, Brenner S (2005) Pemphigus vulgaris triggered by glibenclamide and cilazapril. Acta Dermatovenerol Croat 13:153–155

    PubMed  Google Scholar 

  50. González-Escribano MF, Jiménez G, Walter K, Montes M, Perez-Bernal AM, Rodríguez MR, Conejo-Mir JS, Núñez-Roldán A (1998) Distribution of HLA class II alleles among Spanish patients with pemphigus vulgaris. Tissue Antigens 52:275–278

    Article  PubMed  Google Scholar 

  51. Gough SC, Simmonds MJ (2007) The HLA region and autoimmune disease: associations and mechanisms of action. Curr Genom 8:453–465

    Article  CAS  Google Scholar 

  52. Grando SA, Dahl MV (2000) Nicotine and pemphigus. Arch Dermatol 136:1269

    Article  CAS  PubMed  Google Scholar 

  53. Gul U, Gonul M, Cakmak SK, Kilic A (2006) Pemphigus vulgaris induced by honeybee sting? Acta Derm Venereol 86:467–468

    Article  PubMed  Google Scholar 

  54. Harman KE, Albert S, Black MM (2003) Guidelines for the management of pemphigus vulgaris. Br J Dermatol 149:926–937

    Article  CAS  PubMed  Google Scholar 

  55. Hertl M, Jedlickova H, Karpati S, Marinovic B, Uzun S, Yayli S, Mimouni D, Borradori L, Feliciani C, Ioannides D, Joly P, Kowalewski C, Zambruno G, Zillikens D, Jonkman MF (2015) Pemphigus. S2 Guideline for diagnosis and treatment–guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol 29:405–414

    Article  CAS  PubMed  Google Scholar 

  56. Heymann AD, Chodick G, Kramer E, Green M, Shalev V (2007) Pemphigus variant associated with penicillin use: a case-cohort study of 363 patients from Israel. Arch Dermatol 143:704–707

    Article  CAS  PubMed  Google Scholar 

  57. Iino Y, Hara H, Suda T, Okada T, Baba S, Suzuki H (2005) Co-existence of pemphigus vulgaris and Hashimoto’s thyroiditis. Eur J Dermatol 15:40–42

    PubMed  Google Scholar 

  58. Inamadar AC (1995) Association of alopecia areata, vitiligo and pemphigus vulgaris. Indian J Dermatol Venereol Leprol 61:157–158

    CAS  PubMed  Google Scholar 

  59. Jang HW, Chun SH, Lee JM, Jeon J, Hashimoto T, Kim IH (2014) Radiotherapy-induced pemphigus vulgaris. J Dermatol 41:851–852

    Article  PubMed  Google Scholar 

  60. Javanbakht M, Daneshpazhooh M, Chams-Davatchi C, Eshraghian M, Zarei M, Chamari M (2012) Serum selenium, zinc, and copper in early diagnosed patients with pemphigus vulgaris. Iran J Public Health 41:105–109

    CAS  PubMed  PubMed Central  Google Scholar 

  61. Javor J, Chmurova N, Parnicka Z, Ferencik S, Grosse-Wilde H, Buc M, Svecova D (2010) TNF-alpha and IL-10 gene polymorphisms show a weak association with pemphigus vulgaris in the Slovak population. J Eur Acad Dermatol Venereol 24:65–68

    Article  CAS  PubMed  Google Scholar 

  62. Kaplan RP, Potter TS, Fox JN (1992) Drug-induced pemphigus related to angiotensin-converting enzyme inhibitors. J Am Acad Dermatol 26:364–366

    Article  CAS  PubMed  Google Scholar 

  63. Kaveri SV, Dietrich G, Hurez V, Kazatchkine MD (1991) Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases. Clin Exp Immunol 86:192–198

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Kennedy M, Kim KH, Harten B, Brown J, Planck S, Meshul C, Edelhauser H, Rosenbaum JT, Armstrong CA, Ansel JC (1997) Ultraviolet irradiation induces the production of multiple cytokines by human corneal cells. Investig Ophthalmol Vis Sci 38:2483–2491

    CAS  Google Scholar 

  65. Khan SW, Iftikhar N, Ahmed TA, Bashir M (2015) HLA-DR alleles in pakistani patients of pemphigus vulgaris. J Coll Physicians Surg Pak 25:233–236

    PubMed  Google Scholar 

  66. Kim SC, Won JH, Ahn SK (1993) Pemphigus foliaceus induced by nifedipine. Acta Derm Venereol 73:210–211

    CAS  PubMed  Google Scholar 

  67. Kong YC, Flynn JC (2014) Opportunistic autoimmune disorders potentiated by immune-checkpoint inhibitors anti-CTLA-4 and Anti-PD-1. Front Immunol 5:206. https://doi.org/10.3389/fimmu.2014.00206

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  68. Korang K, Ghohestani R, Krieg T, Uitto J, Hunzelmann N (2002) Exacerbation of pemphigus foliaceus after tetanus vaccination accompanied by synthesis of auto-antibodies against paraneoplastic pemphigus antigens. Acta Derm Venereol 82:482–483

    Article  CAS  PubMed  Google Scholar 

  69. Korman NJ, Stanley JR, Woodley DT (1991) Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen. Arch Dermatol 127:387–390

    Article  CAS  PubMed  Google Scholar 

  70. Kudejko J, Buczkowska J, Trzebuchowska T (1973) Pemphigus erythematosus confined to the post-burn scar. Dermatologica 147:174–178

    Article  CAS  PubMed  Google Scholar 

  71. Kwon HH, Kwon IH, Chung JH, Youn JI (2011) Pemphigus foliaceus associated with psoriasis during the course of narrow-band UVB therapy: a simple coincidence? Ann Dermatol 23:S281–S284

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Kyriakis KP, Vareltzidis AG, Tosca AD (1995) Environmental factors influencing the biologic behavior of patterns of pemphigus vulgaris: epidemiologic approach. Int J Dermatol 34:181–185

    Article  CAS  PubMed  Google Scholar 

  73. Lee HI, Worm M (2009) Advances in the management of UVR-associated skin cancers: autoimmune diseases and UV protection. Br J Dermatol 161(Suppl 3):96–98

    Article  PubMed  Google Scholar 

  74. Liebman TN, Lieberman MR, Burris K (2016) Pemphigus foliaceus exacerbated by radiation, in association with myasthenia gravis. Dermatol Online J 22(3). http://escholarship.org/uc/item/50p1246h (doj_30361). Accessed 10 Oct 2017

  75. Lin R, Ladd DJ Jr, Powell DJ, Way BV (2004) Localized pemphigus foliaceus induced by topical imiquimod treatment. Arch Dermatol 140:889–890

    Article  PubMed  Google Scholar 

  76. Lo Schiavo A, Sangiuliano S, Puca RV, Brunetti G, Ruocco E, Cozzi R (2008) Contact pemphigus: a side-effect of imiquimod therapy. Int J Dermatol 47:765–767

    Article  PubMed  Google Scholar 

  77. Loiseau P, Lecleach L, Prost C, Lepage V, Busson M, Bastuji-Garin S, Roujeau J-C, Charron D (2000) HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus. J Autoimmun 15:67–73

    Article  CAS  PubMed  Google Scholar 

  78. Malik M, Ahmed AR (2007) Concurrence of systemic lupus erythematosus and pemphigus: coincidence or correlation? Dermatology 214:231–239

    Article  PubMed  Google Scholar 

  79. Marfatia YS, Patel S, Makrandi S, Sharma P (2007) Human immunodeficiency virus and pemphigus vulgaris: an interesting association. Indian J Dermatol Venereol Leprol 73:354–355

    Article  CAS  PubMed  Google Scholar 

  80. Marinho RT, Johnson NW, Fatela NM, Serejo FS, Gloria H, Raimundo MO, Velosa JF, Ramalho FJ, Moura MC (2001) Oropharyngeal pemphigus in a patient with chronic hepatitis C during interferon alpha-2a therapy. Eur J Gastroenterol Hepatol 13:869–872

    Article  CAS  PubMed  Google Scholar 

  81. Mehta JN, Martin AG (2000) A case of pemphigus vulgaris improved by cigarette smoking. Arch Dermatol 136:15–17

    Article  CAS  PubMed  Google Scholar 

  82. Mignogna MD, Lo Muzio L, Ruocco E (2000) Pemphigus induction by influenza vaccination. Int J Dermatol 39:800

    CAS  PubMed  Google Scholar 

  83. Miyagawa S, Amagai M, Iida T, Yamamoto Y, Nishikawa T, Shirai T (1999) Late development of antidesmoglein 1 antibodies in pemphigus vulgaris: correlation with disease progression. Br J Dermatol 141:1084–1087

    Article  CAS  PubMed  Google Scholar 

  84. Morell-Dubois S, Carpentier O, Cottencin O, Queyrel V, Hachulla E, Hatron PY, Delaporte E (2008) Stressful life events and pemphigus. Dermatology 216:104–108

    Article  CAS  PubMed  Google Scholar 

  85. Mosaad YM, Fathy H, Fawzy Z, El-Saied MA (2012) Tumor necrosis factor-alpha −308 G>A and interleukin-6 −174 G>C promoter polymorphisms and pemphigus. Hum Immunol 73:560–565

    Article  CAS  PubMed  Google Scholar 

  86. Muramatsu T, Iida T, Ko T, Shirai T (1996) Pemphigus vulgaris exacerbated by exposure to sunlight. J Dermatol 23:559–563

    Article  CAS  PubMed  Google Scholar 

  87. Neumann-Jensen B, Worsaae N, Dabelsteen E, Ullman S (1980) Pemphigus vulgaris and pemphigus foliaceus coexisting with oral lichen planus. Br J Dermatol 102:585–590

    Article  CAS  PubMed  Google Scholar 

  88. Niizeki H, Inamoto N, Nakamura K, Tsuchimoto K, Hashimoto T, Nishikawa T (1994) A case of pemphigus foliaceus after interferon alpha-2a therapy. Dermatology 189(Suppl 1):129–130

    Article  PubMed  Google Scholar 

  89. Ohata C, Koga H, Teye K, Ishii N, Hamada T, Dainichi T, Furumura M, Sato M, Sueki H, Hashimoto T (2013) Concurrence of bullous pemphigoid and herpetiform pemphigus with IgG antibodies to desmogleins 1/3 and desmocollins 1-3. Br J Dermatol 168:879–881

    Article  CAS  PubMed  Google Scholar 

  90. Orion E, Barzilay D, Brenner S (2000) Pemphigus vulgaris induced by diazinon and sun exposure. Dermatology 201:378–379

    Article  CAS  PubMed  Google Scholar 

  91. Orion E, Gazit E, Brenner S (2000) Pemphigus vulgaris possibly triggered by cilazapril. Acta Derm Venereol 80:220

    Article  CAS  PubMed  Google Scholar 

  92. Orion E, Matz H, Wolf R (2004) Pemphigus vulgaris induced by radiotherapy. J Eur Acad Dermatol Venereol 18:508–509

    Article  CAS  PubMed  Google Scholar 

  93. Parodi A, Cozzani E, Milesi G, Drosera M, Rebora A (2002) Fosinopril as a possible pemphigus-inducing drug. Dermatology 204:139–141

    Article  CAS  PubMed  Google Scholar 

  94. Patterson CR, Davies MG (2003) Carbamazepine-induced pemphigus. Clin Exp Dermatol 28:98–99

    Article  CAS  PubMed  Google Scholar 

  95. Patterson CR, Davies MG (2004) Pemphigus foliaceus: an adverse reaction to lisinopril. J Dermatol Treat 15:60–62

    Article  CAS  Google Scholar 

  96. Pavoni DP, Cerqueira LB, Roxo VMMS, Petzl-Erler ML (2006) Polymorphism of the promoter region and exon 1 of the CTLA4 gene in endemic pemphigus foliaceus (fogo selvagem). Braz J Med Biol Res 39:1227–1232

    Article  CAS  PubMed  Google Scholar 

  97. Pellicano R, Iannantuono M, Lomuto M (1993) Pemphigus erythematosus induced by ceftazidime. Int J Dermatol 32:675–676

    Article  CAS  PubMed  Google Scholar 

  98. Pereira NF, Hansen JA, Lin MT, Roxo VM, Braun K, Petzl-Erler ML (2004) Cytokine gene polymorphisms in endemic pemphigus foliaceus: a possible role for IL6 variants. Cytokine 28:233–241

    Article  CAS  PubMed  Google Scholar 

  99. Perry HO, Brunsting LA (1965) Pemphigus foliaceus: further observations. Arch Dermatol 91:10–23

    Article  CAS  PubMed  Google Scholar 

  100. Puca RV, Ruocco E, Lo Schiavo A (2009) Pemphigus and drug addiction. J Eur Acad Dermatol Venereol 23:958

    Article  CAS  PubMed  Google Scholar 

  101. Reis VM, Toledo RP, Lopez A, Diaz LA, Martins JE (2000) UVB-induced acantholysis in endemic pemphigus foliaceus (fogo selvagem) and pemphigus vulgaris. J Am Acad Dermatol 42:571–576

    Article  CAS  PubMed  Google Scholar 

  102. Robati RM, Saeedi M, Alirezayee P (2011) Pemphigus vulgaris and season: are they really related or not? J Eur Acad Dermatol Venereol 25:1235–1236

    Article  CAS  PubMed  Google Scholar 

  103. Rosin MA (1985) Alopecia areata and pemphigus foliaceus. J Am Acad Dermatol 12:895–896

    Article  CAS  PubMed  Google Scholar 

  104. Rossi A, Reszko A, Leach J, Magro CM (2010) Combined bullous pemphigoid and pemphigus vulgaris in an 18-year-old female. J Cutan Pathol 37:991–996

    Article  PubMed  Google Scholar 

  105. Ruocco E, Lo Schiavo A, Caccavale S (2014) Pemphigus induced by radiotherapy for breast cancer: an instance of immunocompromised district. Eur J Dermatol 24:278–279

    PubMed  Google Scholar 

  106. Ruocco E, Ruocco V, Lo Schiavo A, Brunetti G, Wolf R (2014) Viruses and pemphigus: an intriguing never-ending story. Dermatology 229:310–315

    Article  PubMed  Google Scholar 

  107. Ruocco V, Brenner S, Ruocco E (2001) Pemphigus and diet: does a link exist? Int J Dermatol 40:161–163

    Article  CAS  PubMed  Google Scholar 

  108. Russo I, Ferrazzi A, Alaibac M (2016) Relapse of pemphigus vulgaris after topical application of ingenol mebutate. Clin Exp Dermatol 41:664–666

    Article  CAS  PubMed  Google Scholar 

  109. Salmanpour R, Shahkar H, Namazi MR, Rahman-Shenas MR (2006) Epidemiology of pemphigus in south-western Iran: a 10-year retrospective study (1991–2000). Int J Dermatol 45:103–105

    Article  CAS  PubMed  Google Scholar 

  110. Salviano-Silva A, Petzl-Erler ML, Boldt ABW (2017) CD59 polymorphisms are associated with gene expression and different sexual susceptibility to pemphigus foliaceus. Autoimmunity 50:377–385. https://doi.org/10.1080/08916934.2017.1329830

    Article  CAS  PubMed  Google Scholar 

  111. Sarig O, Bercovici S, Zoller L, Goldberg I, Indelman M, Nahum S, Israeli S, Sagiv N, Martinez de Morentin H, Katz O, Baum S, Barzilai A, Trau H, Murrell DF, Bergman R, Hertl M, Rosenberg S, Nothen MM, Skorecki K, Schmidt E, Zillikens D, Darvasi A, Geiger D, Rosset S, Ibrahim SM, Sprecher E (2012) Population-specific association between a polymorphic variant in ST18, encoding a pro-apoptotic molecule, and pemphigus vulgaris. J Investig Dermatol 132:1798–1805

    Article  CAS  PubMed  Google Scholar 

  112. Shahkar H, Fallahzadeh MK, Namazi MR (2010) ABO blood groups and pemphigus vulgaris: no relationship. Acta Dermatoven APA 19(1):49–51

    CAS  Google Scholar 

  113. Sharma VK, Bhari N, Gupta S, Sahni K, Khanna N, Ramam M, Sethuraman G (2016) Clinical efficacy of rituximab in the treatment of pemphigus: a retrospective study. Indian J Dermatol Venereol Leprol 82:389–394

    Article  PubMed  Google Scholar 

  114. Sinha AA (2011) The Genetics of Pemphigus. Dermatol Clin 29:381–391

    Article  CAS  PubMed  Google Scholar 

  115. Stojanovich L, Marisavljevich D (2008) Stress as a trigger of autoimmune disease. Autoimmun Rev 7:209–213

    Article  PubMed  Google Scholar 

  116. Su Z, Liu G, Liu J, Fang T, Zeng Y, Zhang H, Yang S, Wang Y, Zhang J, Wei J, Li Y, Guo Y (2015) Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma: report of a case and review of literature. Int J Clin Exp Pathol 8:11983–11994

    PubMed  PubMed Central  Google Scholar 

  117. Sullivan TP, Elgart GW, Kirsner RS (2002) Pemphigus and smoking. Int J Dermatol 41:528–530

    Article  PubMed  Google Scholar 

  118. Tamir A, Ophir J, Brenner S (1994) Pemphigus vulgaris triggered by emotional stress. Dermatology 189:210

    Article  CAS  PubMed  Google Scholar 

  119. Tan SR, McDermott MR, Castillo CJ, Sauder DN (2006) Pemphigus vulgaris induced by electrical injury. Cutis 77:161–165

    PubMed  Google Scholar 

  120. Tanasilovic S, Popadic S, Medenica L, Popadic D (2017) Pemphigus vulgaris and pemphigus foliaceus determined by CD86 and CTLA4 polymorphisms. Clin Dermatol 35:236–241. https://doi.org/10.1016/j.clindermatol.2016.05.021

    Article  PubMed  Google Scholar 

  121. Tavakolpour S (2016) Interleukin 21 as a new possible player in pemphigus: is it a suitable target? Int Immunopharmacol 34:139–145

    Article  CAS  PubMed  Google Scholar 

  122. Tavakolpour S (2016) The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: a review of literature. J Res Med Sci 21:37. https://doi.org/10.4103/1735-1995.183992

    Article  PubMed  PubMed Central  Google Scholar 

  123. Tavakolpour S, Alavian SM, Sali S (2016) Hepatitis B reactivation during immunosuppressive therapy or cancer chemotherapy, management, and prevention: a comprehensive review. Hepat Mon 16:e35810. https://doi.org/10.5812/hepatmon.35810

    PubMed  PubMed Central  Google Scholar 

  124. Tavakolpour S, Daneshpazhooh M, Mahmoudi H (2017) Skin cancer: genetics, immunology, treatments, and psychological care. In: Mehdipour P (ed) Cancer genetics and psychotherapy. Springer International Publishing, Cham, pp 851–934. https://doi.org/10.1007/978-3-319-64550-6_18

    Chapter  Google Scholar 

  125. Tavakolpour S, Daneshpazhooh M, Mahmoudi HR, Balighi K (2016) The dual nature of retinoic acid in pemphigus and its therapeutic potential: special focus on all-trans retinoic Acid. Int Immunopharmacol 36:180–186

    Article  CAS  PubMed  Google Scholar 

  126. Tavakolpour S, Kheiry F, Mirsafaei HS, Akhlaghdoust M (2016) The possible role of interleukin-35 and its therapeutic potential in pemphigus. Int Immunopharmacol 42:11–17

    Article  PubMed  CAS  Google Scholar 

  127. Tavakolpour S, Mirsafaei HS, Delshad S (2017) Management of pemphigus disease in pregnancy. Am J Reprod Immunol 77:e12601. https://doi.org/10.1111/aji.12601

    Article  CAS  Google Scholar 

  128. Tavakolpour S, Rahimzadeh G (2016) New insights into the management of patients with autoimmune diseases or inflammatory disorders during pregnancy. Scand J Immunol 84:146–149

    Article  PubMed  Google Scholar 

  129. Tavakolpour S, Soori T, Noormohammadpour P, Balighi K, Mahmoudi H, Daneshpazhooh M (2017) Rituximab administration in a patient with pemphigus vulgaris following reactivation of occult hepatitis B virus infection. Dermatol Online J 23(6). http://escholarship.org/uc/item/8927s9kt (doj_35399). Accessed 10 Oct 2017

  130. Tavakolpour S, Tavakolpour V (2016) Interleukin 4 inhibition as a potential therapeutic in pemphigus. Cytokine 77:189–195

    Article  PubMed  CAS  Google Scholar 

  131. Thimon S, Machet L, Machet MC, Samimi M, Maruani A (2014) Pemphigus induced by radiotherapy for breast cancer: clinical, immunological and histological features of one case with antidesmoglein immunostaining. Eur J Dermatol 24:119–120

    PubMed  Google Scholar 

  132. Tirado-Sanchez A, Ponce-Olivera RM (2016) Pemphigus vulgaris and blood group antigens: no relationship. Clin Exp Dermatol 41:685

    Article  CAS  PubMed  Google Scholar 

  133. Torres T, Ferreira M, Sanches M, Selores M (2009) Pemphigus vegetans in a patient with colonic cancer. Indian J Dermatol Venereol Leprol 75:603–605

    Article  PubMed  Google Scholar 

  134. Torzecka JD, Narbutt J, Sysa-Jedrzejowska A, Borowiec M, Ptasinska A, Woszczek G, Kowalski ML (2003) Tumour necrosis factor-alpha polymorphism as one of the complex inherited factors in pemphigus. Mediators Inflamm 12:303–307

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  135. Toumi A, Abida O, Ben Ayed M, Masmoudi A, Turki H, Masmoudi H (2013) Cytokine gene polymorphisms in Tunisian endemic pemphigus foliaceus: a possible role of il-4 variants. Hum Immunol 74:658–665

    Article  CAS  PubMed  Google Scholar 

  136. Tsankov N, Kazandjieva J, Gantcheva M (1998) Contact pemphigus induced by dihydrodiphenyltrichlorethane. Eur J Dermatol 8:442–443

    CAS  PubMed  Google Scholar 

  137. Tsankov N, Vassileva S, Kamarashev J, Kazandjieva J, Kuzeva V (2000) Epidemiology of pemphigus in Sofia, Bulgaria. A 16-year retrospective study (1980–1995). Int J Dermatol 39:104–108

    Article  CAS  PubMed  Google Scholar 

  138. Valikhani M, Kavand S, Toosi S, Kavand G, Ghiasi M (2007) ABO blood groups, rhesus factor and pemphigus. Indian J Dermatol 52:176–178

    Article  Google Scholar 

  139. Valikhani M, Kavusi S, Chams-Davatchi C, Daneshpazhooh M, Barzegari M, Ghiasi M, Abedini R (2007) Pemphigus and associated environmental factors: a case-control study. Clin Exp Dermatol 32:256–260

    Article  CAS  PubMed  Google Scholar 

  140. Valikhani M, Kavusi S, Chams-Davatchi C, Hallaji Z, Esmaili N, Ghandi N, Farahani F, Lajevardi V (2008) Impact of smoking on pemphigus. Int J Dermatol 47:567–570

    Article  PubMed  Google Scholar 

  141. Vodo D, Sarig O, Geller S, Ben-Asher E, Olender T, Bochner R, Goldberg I, Nosgorodsky J, Alkelai A, Tatarskyy P, Peled A, Baum S, Barzilai A, Ibrahim SM, Zillikens D, Lancet D, Sprecher E (2016) Identification of a functional risk variant for pemphigus vulgaris in the ST18 gene. PLoS Genet 12:e1006008. https://doi.org/10.1371/journal.pgen.1006008

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  142. Wang M, Liang L, Li L, Han K, Li Q, Peng Y, Peng X, Zeng K (2017) Increased miR-424-5p expression in peripheral blood mononuclear cells from patients with pemphigus. Mol Med Rep 15:3479–3484

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  143. Webster G, Marques PM, Ortega Filho RC, Sousa Ade O, Salmito MC (2013) Paraneoplastic pemphigus: initial manifestation of lung cancer. Braz J Otorhinolaryngol 79:258

    Article  PubMed  Google Scholar 

  144. Wilkinson SM, Smith AG, Davis MJ, Hollowood K, Dawes PT (1992) Rheumatoid arthritis: an association with pemphigus foliaceous. Acta Derm Venereol 72:289–291

    CAS  PubMed  Google Scholar 

  145. Wohl Y, Brenner S (2003) Pemphigus in Israel—an epidemiologic analysis of cases in search of risk factors. Isr Med Assoc J 5:410–412

    PubMed  Google Scholar 

  146. Wohl Y, Goldberg I, Shirazi I, Brenner S (2006) Chlorpyrifos exacerbating pemphigus vulgaris: a preliminary report and suggested in vitro immunologic evaluation model. Skinmed 5:111–113

    Article  PubMed  Google Scholar 

  147. Wohl Y, Mashiah J, Kutz A, Hadj-Rabia S, Cohen AD (2015) Pemphigus and depression comorbidity: a case control study. Eur J Dermatol 25:602–605

    CAS  PubMed  Google Scholar 

  148. Yalcin B, Alli N (2007) Pemphigus vulgaris following antirabies vaccination. J Dermatol 34:734–735

    Article  PubMed  Google Scholar 

  149. Yamashina Y, Miyagawa S, Kawatsu T, Iida T, Higashimine I, Shirai T, Kaneshige T (1998) Polymorphisms of HLA class II genes in Japanese patients with pemphigus vulgaris. Tissue Antigens 52:74–77

    Article  CAS  PubMed  Google Scholar 

  150. Yan L, Wang JM, Zeng K (2012) Association between HLA-DRB1 polymorphisms and pemphigus vulgaris: a meta-analysis. Br J Dermatol 167:768–777

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  151. Yazdanpanah MJ, Ghayour-Mobarhan M, Taji A, Javidi Z, Pezeshkpoor F, Tavallaie S, Momenzadeh A, Esmaili H, Shojaie-Noori S, Khoddami M, Sahebkar A (2011) Serum zinc and copper status in Iranian patients with pemphigus vulgaris. Int J Dermatol 50:1343–1346

    Article  CAS  PubMed  Google Scholar 

  152. Ye B, Liu X, Li X, Kong H, Tian L, Chen Y (2015) T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance. Cell Death Dis 6:e1694. https://doi.org/10.1038/cddis.2015.42

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  153. Zakka LR, Shetty SS, Ahmed AR (2012) Rituximab in the treatment of pemphigus vulgaris. Dermatol Ther 2:17

    Article  Google Scholar 

  154. Zandman-Goddard G, Levy Y, Shoenfeld Y (2005) Intravenous immunoglobulin therapy and systemic lupus erythematosus. Clin Rev Allergy Immunol 29:219–228

    Article  CAS  PubMed  Google Scholar 

  155. Zarei M, Javanbakht MH, Chams-Davatchi C, Daneshpazhooh M, Eshraghian MR, Daneshpazhooh M, De-Rakhshanian H, Djalali M (2014) Evaluation of vitamin D status in newly diagnosed pemphigus vulgaris patients. Iran J Public Health 43:1544–1549

    PubMed  PubMed Central  Google Scholar 

  156. Zone J, Ward J, Boyce E, Schupbach C (1982) Penicillamine-induced pemphigus. JAMA 247:2705–2707

    Article  CAS  PubMed  Google Scholar 

Related articles recently published in Archives of Dermatological Research (selected by the journal’s editorial staff)

  1. Pedroni MN, Hirotsu C, Porro AM, Tufik S, Andersen ML (2017) The role of sleep in pemphigus: a review of mechanisms and perspectives. Arch Dermatol Res. https://doi.org/10.1007/s00403-017-1765-9

    PubMed  Google Scholar 

  2. Sun XK, Chen JF, Shen H (2016) Immunohistochemical study of toll-like receptors 2, 4, and 9 expressions in pemphigus and bullous pemphigoid lesions. Arch Dermatol Res 308:429–436

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Soheil Tavakolpour

  2. Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran

    Soheil Tavakolpour

Authors
  1. Soheil Tavakolpour
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Soheil Tavakolpour.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Funding

There is no funding source.

Ethical approval

This article does not contain any studies with human participants or animals performed by the author.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tavakolpour, S. Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus. Arch Dermatol Res 310, 95–106 (2018). https://doi.org/10.1007/s00403-017-1790-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-017-1790-8

Keywords

Search

Navigation